216 related articles for article (PubMed ID: 15375504)
1. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
2. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
3. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
4. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
7. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
8. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
9. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
Chen B; Campos EI; Crawford R; Martinka M; Li G
Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
11. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
Cheung KJ; Bush JA; Jia W; Li G
Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
[TBL] [Abstract][Full Text] [Related]
12. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
13. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.
Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A
J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor ING1: structure and function.
Cheung KJ; Li G
Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
[TBL] [Abstract][Full Text] [Related]
15. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I
Cancer Res; 1997 Apr; 57(7):1255-8. PubMed ID: 9102209
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
[TBL] [Abstract][Full Text] [Related]
17. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
[TBL] [Abstract][Full Text] [Related]
18. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair.
Campos EI; Martinka M; Mitchell DL; Dai DL; Li G
Int J Oncol; 2004 Jul; 25(1):73-80. PubMed ID: 15201991
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of the p53 tumor suppressor pathway in head and neck cancer.
Hoque MO; Kawamata H; Nakashiro K; Omotehara F; Hino S; Uchida D; Harada K; Begum NM; Yoshida H; Sato M; Fujimori T
Int J Oncol; 2002 Jul; 21(1):119-26. PubMed ID: 12063558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
